Views & Analysis The art of storytelling in clinical data communication − wha... What can we learn from Batman and the Joker, the greatest hero/villain pairing of all time?
Views & Analysis Medical affairs: learning to change behaviour? Research points to the need for greater engagement with behavioural science among medical affairs professionals.
Views & Analysis Face-to-face learning in a digital world Traditional ways of interacting should not be forgotten in a digital world.
Views & Analysis Horses or zebras: inspiring behavioural change to make the r... Insight into human behaviour allows development of programmes that help doctors diagnose rare diseases.
Views & Analysis New research: can pharma get healthy rewards for good behavi... Research shows industry needs to see more evidence of success for wider adoption.
Views & Analysis Behavioural science + medical education: a transformative co... ‘We need to walk in the shoes of HCPs and patients if we are to design programmes that improve health outcomes.’
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
